| Patent application number | Description | Published |
|---|
| 20080207636 | Compounds Effecting Glucokinase - The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R | 08-28-2008 |
| 20080280872 | Benzamide Derivatives and Their Use as Glucokinase Activating Agents - Compounds of Formula (I): wherein: R | 11-13-2008 |
| 20080280874 | Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and Obesity - Compounds of Formula (I): | 11-13-2008 |
| 20080312207 | Compounds - Compounds of Formula (I) wherein: R1 is methyl; R2 is selected from —C (O) NR4R5, SO2NR4R5, S (O) pR4 and HET-2; HET-1 is a 5- or 6-membered, optionally substituted C-linked heteroaryl ring; HET-2 is a 4-, 5- or 6-membered, C- or N-linked optionally substituted heterocyclyl ring; R3 is selected from halo, fluoromethyl, difluoromethyl, trifluoromethyl, methyl, methoxy and cyano; R4 is selected from for example hydrogen, optionally substituted (1-4C) alkyl and HET-2; R5 is hydrogen or (1-4C) alkyl; or R4 and R5 together with the nitrogen atom to which they are attached may form a heterocyclyl ring system as defined by HET-3; HET-3 is for example an optionally substituted N-linked, 4, 5 or 6 membered, saturated or partially unsaturated heterocyclyl ring; p is (independently at each occurrence) 0, 1 or 2; m is 0 or 1; n is 0, 1 or 2; provided that when m is 0, then n is 1 or 2; or a salt, pro drug or solvate thereof, are described. Their use as GLK activators, pharmaceutical compositions containing them and processes for their preparation are also described. | 12-18-2008 |
| 20090018157 | Chemical compounds - Compounds of Formula (I) wherein: R | 01-15-2009 |
| 20090062351 | Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators - A compound of Formula (I): Formula (I) wherein: R | 03-05-2009 |
| 20090124682 | Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity - A compound of the formula (1) or a pharmaceutically-acceptable salt: (A chemical formula should be inserted here—please see paper copy enclosed herewith) (1) possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described. | 05-14-2009 |
| 20090253676 | Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes - Compounds of Formula (I): | 10-08-2009 |
| 20100029727 | 1, 3, 4 -OXADIAZOLE DERIVATIVES AS DGAT1 INHIBITORS - Compounds of formula (I), or salts thereof, which inhibit acetyl CoA (acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, | 02-04-2010 |
| 20110071144 | QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - The invention relates to quinazoline derivatives of formula (1) | 03-24-2011 |
